LYZZ Capital

LYZZ Capital is a healthcare-focused venture capital and private equity firm, investing through funds denominated in both US and Chinese currencies. Its team is made up of investment and operating professionals with backgrounds at pharmaceutical and biotechnology companies as well as Wall Street firms, combining scientific, medical and financial expertise, and has worked together for more than a decade in what it describes as a cordial, team-oriented environment. The team's biotechnology investing experience extends back more than 20 years, including over 15 years working in China. The firm says it invests in talent, assets and technologies on a global basis, with particular emphasis on unmet medical needs and substantial market opportunities specifically within China.